Topiramate Tablet, Film Coated
Product Images NDC 72789-471

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72789-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789471 Label (72789471)

This is a prescription for Topiramate 25 mg tablets, with a total of 90 tablets. The medication should be stored out of the reach of children and it is advised to consult a doctor for medical advice on side effects. The tablets need to be taken a certain number of times per day. Each tablet is coated and contains 25 mg of Topiramate. The prescription includes specific lot and expiration date information. Additionally, there is a reference to a Medication Guide available online.*

FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

FDA Label Image

Figure 2 (Topiramate Fig2)

This document presents a study evaluating the effectiveness of topiramate at different doses (50mg/day, 100mg/day, 200mg/day) compared to placebo. The study involved a significant number of participants (N=115, N=114, N=117, N=117, N=125, N=120, N=112, N=117). The results show changes from baseline to double-blind phase in average monthly rates of a specific condition. The statistical significance levels are marked with "*" and "**" denoting p<0.01 and p<0.001, respectively.*

FDA Label Image

Chemical Structure (Topiramate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.